Clinical Trial Details
EORTC-18952
Back to Clinical Trials Database
Randomized phase III trial. Post-operative adjuvant Interferon-alpha 2b (Intron-A) treatment after resection of thick primary melanoma and/or regional lymphnode metastases "intermediate-high dose" vs "intermediate-low dose" Interferon-alpha vs observation.
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 20-Mar-1996 Date Step1 close: 15-Jun-2000 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 1400 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00002763 |
| NCT number | NCT00002763 |
